VMD: Explanation for consolidated business result in reviewed semiannual FS of 2014

Vimedimex Medi – Pharma Joint Stock Company explained business result in reviewed semiannual financial statements of 2014 compared to reviewed semiannual financial statements of 2013 as follows:

-  Net revenue in the first 06 months of 2014 increased by 10.34% or VND513.07 billion and cost of goods sold increased by 10.72%  or VND487.18 billion, leading to gross profit from selling and service supply increased 6.2% or VND25.88 billion compared the same period of last year.

-  Net profit in the first 06 months of 2014 increased 207.55% or VND8.23 billion compared the same period of last year.

-  Therefore, profit after tax in the first 06 months of 2014 increased VND5.14 billion, equivalent 203.88% compared the same period of last year.

HOSE

>   BT6: Explanation for consolidated business results for 6 months of 2014 before & after review (12/09/2014)

>   STSC: Change of Head Office Address (12/09/2014)

>   HSG: Setting up a Branch (12/09/2014)

>   NHS: The record date for the 2014 AGM (12/09/2014)

>   SDD: Reviewed financial statement 2014 (12/09/2014)

>   V21: Explanation for auditor's opinion in the semi-annual financial statement 2014 (12/09/2014)

>   KHB: Explanation for auditor\u2019s opinion in the semi-annual financial statement 2014 (11/09/2014)

>   LHC: Explanation for the difference in the profit after tax in Quarter II.2014 of Holding Company year on year (11/09/2014)

>   TS4: Explanation for consolidated business results for 6 months of 2014 before & after review (11/09/2014)

>   TS4: Explanation for business results for 6 months of 2014 before & after review (Parent company) (11/09/2014)